Jump to main content

yr 〜
yr

Search results 2

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis. 21 6
Digital博士論文障害者向け資料あり
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences
National Diet Library
  • Subject Headingnon-alcoholic steatohepatitis hepatic fibrogenesis hepatocarcinogenesis canagliflozin teneligliptin
  • Note (General)... inhibitor and teneligliptin (TE) on non-diabetic NASH pro...

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.
Digital博士論文
Ozutsumi, Takahiro, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Tsuji, Yuki, Kaya, Daisuke, Fujinaga, Yukihisa, Furukawa, Masanori, Nakanishi, Keisuke, Sato, Shinya, Sawada, Yasuhiko, Saikawa, Soichiro, Kitagawa, Koh, Takaya, Hiroaki, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Noguchi, Ryuichi, Akahane, Takemi, Mitoro, Akira, Yoshiji, HitoshiMDPI2020-03-21International journal of molecular sciences21 6p.Article No.2164-
Available onlineOther Libraries in Japan
  • Subject Headingnon-alcoholic steatohepatitis hepatic fibrogenesis hepatocarcinogenesis canagliflozin teneligliptin
  • Note (General)... inhibitor and teneligliptin (TE) on non-diabetic NASH pro...

Reached to the end of result.

RSS